Predictors of survival in children with methymalonic acidemia with homocystinuria in Beijing, China: a prospective cohort study.

OBJECTIVE (i) To determine whether clinical features and biochemical parameters help to predict survival of methylmalonic acidemia with homocystinuria; (ii) To find the cutoff values of biochemical parameters for predicting survival of methylmalonic acidemia with homocystinuria. DESIGN A prospective cohort study. SETTING A pediatric tertiary hospital in Beijing; all patients were followed until death or June 2013. SUBJECTS 45 pediatric patients diagnosed with methylmalonic acidemia with homocystinuria between 2006 and 2012. OUTCOME MEASURES The data of clinical characteristics and pretreatment biochemical parameters were collected. The Cox regression analysis was performed to identify independent risk factors for survival of patients with methylmalonic acidemia and homocystinuria. The best cutoff values for these independent factors were determined by the receiver characteristic curve. RESULTS Newborn onset (OR=6.856, 95%CI=2.241-20.976, P=0.001), high level of methylmalonic acid in urine (OR=1.022, 95%CI=1.011-1.033, P<0.001), and high level of urea in serum (OR=1.083, 95%CI=1.027-1.141, P=0.003) were independent negative risk factors for survival of patients with methylmalonic acidemia and homocystinuria. The cutoff values of maximum predictive accuracy of methylmalonic acid in urine and urea in serum were respectively 5.41 mmol/mmol creatinine and 7.80 mmol/L by receiver operating characteristic curve analysis. CONCLUSIONS The patients of methylmalonic acidemia with homocystinuria tend to have an adverse outcome if they have newborn onsets. Elevated urea and urinary methylmalonic acid are predictors of adverse outcomes for the patients. They show similar effect for predicting severe adverse prognosis. The combination of methylmalonic acid in urine concentration and urea in serum concentration provided the most accurate predictive tool.

[1]  M. Baumgartner,et al.  Long-Term Outcome in Methylmalonic Acidurias Is Influenced by the Underlying Defect (mut0, mut−, cblA, cblB) , 2007, Pediatric Research.

[2]  Y. Li,et al.  Impact of Inborn Errors of Metabolism on Admission in a Neonatal Intensive Care Unit—A Prospective Cohort Study , 2012, The Indian Journal of Pediatrics.

[3]  P. Durand,et al.  Acute methionine load‐induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage‐derived tissue factor activity in rats , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  R. Surtees,et al.  The aetiology of neurological complications of organic acidaemias—A role for the blood–brain barrier , 2006, Journal of Inherited Metabolic Disease.

[5]  W. Tu.  Methylmalonic Acidemia in Mainland China , 2011, Annals of Nutrition and Metabolism.

[6]  R. Chandler,et al.  Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management , 2012, Journal of Inherited Metabolic Disease.

[7]  F. Ledley,et al.  Benign methylmalonic aciduria. , 1984, The New England journal of medicine.

[8]  M. Seashore,et al.  Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC) , 1997, Journal of Inherited Metabolic Disease.

[9]  Yi Wang,et al.  The screening of inborn errors of metabolism in sick Chinese infants by tandem mass spectrometry and gas chromatography/mass spectrometry. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[10]  S. Kölker,et al.  Current concepts in organic acidurias: understanding intra- and extracerebral disease manifestation , 2013, Journal of Inherited Metabolic Disease.

[11]  V. Shotelersuk,et al.  Clinical and molecular findings in Thai patients with isolated methylmalonic acidemia. , 2012, Molecular genetics and metabolism.

[12]  X. Gu,et al.  [Outcomes of patients with combined methylmalonic acidemia and homocystinuria after treatment]. , 2013, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[13]  N. Boddaert,et al.  Long-term outcome in methylmalonic aciduria: a series of 30 French patients. , 2009, Molecular genetics and metabolism.

[14]  Zhixian Yang,et al.  Epilepsy in children with methylmalonic acidemia: Electroclinical features and prognosis , 2011, Brain and Development.

[15]  K. Woo,et al.  Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. , 1997, Circulation.

[16]  K. Robinson,et al.  Homocysteine and coronary atherosclerosis. , 1996, Journal of the American College of Cardiology.

[17]  S. Kölker,et al.  Neurodegeneration and chronic renal failure in methylmalonic aciduria—A pathophysiological approach , 2008, Journal of Inherited Metabolic Disease.

[18]  Yuehua Zhang,et al.  [Clinical studies on fifty-seven Chinese patients with combined methylmalonic aciduria and homocysteinemia]. , 2007, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[19]  D. Nagaraja,et al.  Screening for inborn errors of metabolism using automated electrospray tandem mass spectrometry: study in high-risk Indian population. , 2010, Clinical biochemistry.

[20]  S. Kölker,et al.  Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative? , 2012, Journal of Inherited Metabolic Disease.

[21]  A. Munnich,et al.  Multiple OXPHOS Deficiency in the Liver, Kidney, Heart, and Skeletal Muscle of Patients With Methylmalonic Aciduria and Propionic Aciduria , 2009, Pediatric Research.

[22]  J. Stamler,et al.  Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. , 1993, The Journal of clinical investigation.